Status:
UNKNOWN
Transgender Post-reassignment Urogynecologic Measures and Perceptions
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Icahn School of Medicine at Mount Sinai
The Cleveland Clinic
Conditions:
Gender Identity Disorder of Adult
Voiding Disorders
Eligibility:
MALE
18+ years
Brief Summary
The intent of this mixed methods study for transgender women after gender confirmation surgery is to characterize and subsequently create a validated screening questionnaire for postoperative urologic...
Eligibility Criteria
Inclusion
- Stage 1 -- Male-to-female transgender women who are at least 4 weeks postoperative following genital surgery for gender confirmation
- Stage 2 -- Male-to-female transgender women who are scheduled to undergo surgery or are within 4 weeks postoperative
- Both stages -- Minimum age 18 years old
- Both stages -- English fluency
- Both stages -- Reliable contact information and/or permanent residence
Exclusion
- Preexisting pelvic pathology, including abnormal anatomy or baseline voiding dysfunction
- Urinary or intestinal problems prior to surgery lasting greater than 6 weeks
Key Trial Info
Start Date :
December 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03293771
Start Date
December 27 2017
End Date
December 31 2019
Last Update
April 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10065